TRVI logo

Trevi Therapeutics, Inc. (TRVI) Return On Equity

Annual ROE:

-52.59%-22.00%(-71.92%)
December 31, 2024

Summary

  • As of today, TRVI annual return on equity is -52.59%, with the most recent change of -22.00% (-71.92%) on December 31, 2024.
  • During the last 3 years, TRVI annual ROE has risen by +100.44% (+65.63%).
  • TRVI annual ROE is now -182.58% below its all-time high of 63.68%, reached on December 1, 2016.

Performance

TRVI ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIprofitability metrics

Quarterly ROE:

-45.24%+14.46%(+24.22%)
June 30, 2025

Summary

  • As of today, TRVI quarterly return on equity is -45.24%, with the most recent change of +14.46% (+24.22%) on June 30, 2025.
  • Over the past year, TRVI quarterly ROE has increased by +2.54% (+5.32%).
  • TRVI quarterly ROE is now -181.17% below its all-time high of -16.09%, reached on December 1, 2017.

Performance

TRVI Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

TRVI ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-71.9%+5.3%
3Y3 Years+65.6%+66.0%
5Y5 Years+38.6%+18.0%

TRVI ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-71.9%+65.6%-70.4%+41.1%
5Y5-Year-71.9%+65.6%-70.4%+77.9%
All-TimeAll-Time-182.6%+73.1%-181.2%+77.9%

TRVI ROE History

DateAnnualQuarterly
Jun 2025
-
-45.24%(+24.2%)
Mar 2025
-
-59.70%(+5.4%)
Dec 2024
-52.59%(-71.9%)
-63.10%(-5.3%)
Sep 2024
-
-59.95%(-25.5%)
Jun 2024
-
-47.78%(-25.6%)
Mar 2024
-
-38.03%(-24.7%)
Dec 2023
-30.59%(+34.7%)
-30.50%(-14.9%)
Sep 2023
-
-26.55%(+7.7%)
Jun 2023
-
-28.77%(+20.5%)
Mar 2023
-
-36.18%(+24.2%)
Dec 2022
-46.82%(+69.4%)
-47.73%(+37.9%)
Sep 2022
-
-76.83%(+42.2%)
Jun 2022
-
-132.96%(+35.1%)
Mar 2022
-
-204.75%(-17.2%)
Dec 2021
-153.03%
-174.67%(-15.7%)
DateAnnualQuarterly
Sep 2021
-
-151.01%(-24.3%)
Jun 2021
-
-121.46%(-29.0%)
Mar 2021
-
-94.15%(-17.4%)
Dec 2020
-80.07%(+6.6%)
-80.18%(-28.0%)
Sep 2020
-
-62.62%(-13.5%)
Jun 2020
-
-55.15%(+10.0%)
Mar 2020
-
-61.30%(+5.0%)
Dec 2019
-85.70%(+56.1%)
-64.52%(+6.8%)
Sep 2019
-
-69.22%(+13.1%)
Jun 2019
-
-79.61%(+51.8%)
Mar 2019
-
-165.32%(+4.7%)
Dec 2018
-195.42%(-124.6%)
-173.50%(-254.4%)
Jun 2018
-
-48.96%(-204.3%)
Dec 2017
-87.02%(-236.7%)
-
Dec 2017
-
-16.09%
Dec 2016
63.68%
-

FAQ

  • What is Trevi Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual ROE year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly ROE year-on-year change?

What is Trevi Therapeutics, Inc. annual return on equity?

The current annual ROE of TRVI is -52.59%

What is the all-time high annual ROE for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual return on equity is 63.68%

What is Trevi Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, TRVI annual return on equity has changed by -22.00% (-71.92%)

What is Trevi Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of TRVI is -45.24%

What is the all-time high quarterly ROE for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly return on equity is -16.09%

What is Trevi Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, TRVI quarterly return on equity has changed by +2.54% (+5.32%)
On this page